InvestorsHub Logo
Followers 45
Posts 7008
Boards Moderated 0
Alias Born 02/24/2004

Re: NagStocks post# 6380

Sunday, 09/03/2017 3:27:54 PM

Sunday, September 03, 2017 3:27:54 PM

Post# of 8023
Yes, Ixmyelocel-T, is a patient-specific multicellular therapy, and if my memory serves me correctly, Ixmyelocel-T has been in development since the mid 1990's, originating from the scientist from the University of Michigan, and got ophan drug status back in 2009, and was renamed Ixmyelocel-t in March of 2011, or something like that.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent VCEL News